Drug Target Review – Issue 1 2021
In this issue, find articles discussing how high-throughput experimentation can enhance automated molecular discovery, why bNAbs present a promising COVID-19 treatment and how a novel rhinovirus vaccine was developed. Also included are features on immuno-oncology, cell line development and assays.
Included in this issue:
- VACCINE DEVELOPMENT
The development of biomaterial-based vaccine platforms against viruses
Dr Sushma Kumari, Dr Sonal Asthana and Dr Kaushik Chatterjee, Indian Institute of Science
- CELL LINE DEVELOPMENT
Which CHO cell is the right CHO cell?
Dr Louis Boon, Polpharma Biologics Utrecht
Fighting HIV: could antibodies be the answer?
Victoria Rees, Drug Target Review
- LAB AUTOMATION
Expanding accessible chemical space through automated high-throughput experimentation
Dr Sam Liver, The Rosalind Franklin Institute
COVID-19 drug targets and cell-based assays
Sheraz Gul, Fraunhofer Institute and Alp Tegin Sahin, Kadir Has University
Synthesising very long-chain fatty acids to treat retinal conditions
Dr Paul Bernstein, University of Utah
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!